High Burden of Cardiovascular Disease Risk Factors in Mexico: An Epidemic of Ischemic Heart Disease That May Be on Its Way?
Overview
Affiliations
Background: Whereas developed nations have witnessed a drop in the occurrence and mortality of ischemic heart disease, developing nations have recorded a constant rise. The burden of cardiovascular disease risk factors may explain this increase.
Methods: We conducted a population-based cross-sectional survey to estimate the prevalence of cardiovascular risk factors in the population protected by the Mexican Social Security Institute. A total of 20,062 Mexicans, aged >or=20 years, 43.5% (8,727) male and 56.5% (11,335) female, randomly selected in a 4-stage stratified population-based sampling process were included.
Results: The most prevalent cardiovascular risk factor in men was smoking (31.9%), whereas in women, it was obesity (26.6%) and central obesity (49.7%). A similar high age-adjusted prevalence was observed in women and men for hypertension (29.7% and 28.8%), diabetes (12.94% and 12.66%), and hypercholesterolemia (13.81% and 12.36%). There was a clear age effect on the prevalence of diabetes, hypertension, and hypercholesterolemia, with increasing prevalence with aging. Smoking also had an age effect, but its prevalence increases as age diminishes. More than half of the subjects in reproductive age (20-44 years old) have at least 1 cardiovascular risk factor, mainly smoking.
Conclusions: Cardiovascular risk factors are highly prevalent in the Mexican population, which seems to be between the second and third stages of the tobacco epidemic. The increased prevalence of risk factors clustering indicates the need for comprehensive integrated management of cardiovascular risk factors in Mexicans, with special emphasis on individuals at younger ages.
Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart Disease.
Garcia-Cruz E, Manzur-Sandoval D, Gopar-Nieto R, Plata-Corona J, Montalvo-Ocotoxtle I, Navarro-Martinez D JACC Adv. 2024; 2(8):100596.
PMID: 38938341 PMC: 11198451. DOI: 10.1016/j.jacadv.2023.100596.
Padilla-Rivas G, Delgado-Gallegos J, Garza-Trevino G, Galan-Huerta K, G-Buentello Z, Roacho-Perez J Front Public Health. 2022; 10:1008565.
PMID: 36438268 PMC: 9686003. DOI: 10.3389/fpubh.2022.1008565.
Chivardi C, Hutchinson B, Molina V, Moreno E, Fajardo I, Giraldo-Arcila G Rev Panam Salud Publica. 2022; 46:e144.
PMID: 36128473 PMC: 9473450. DOI: 10.26633/RPSP.2022.144.
Loud E, Gallegos-Carrillo K, Barrientos-Gutierrez I, Arillo-Santillan E, Lambert V, Zavala-Arciniega L Int J Environ Res Public Health. 2021; 18(20).
PMID: 34682643 PMC: 8535597. DOI: 10.3390/ijerph182010905.
Giglio R, Carruba G, Cicero A, Banach M, Patti A, Nikolic D Metabolites. 2020; 10(11).
PMID: 33114614 PMC: 7694062. DOI: 10.3390/metabo10110428.